LifeMine Therapeutics Appoints Elliot Ehrich, M.D., as Chief Medical Officer and EVP of Translational Science and Lata Jayaraman, Ph.D., as EVP, Head of Biology

LifeMine Therapeutics Appoints Jennifer A. Jarrett to Board of Directors

LifeMine Therapeutics Expands Management Team with Appointments of Martin Stahl, Ph.D., as Chief Scientific Officer and Louis Plamondon, Ph.D., as Executive Vice President and Head of CMC

Fierce Biotech names LifeMine Therapeutics as one of its “Fierce 15” Biotech Companies of 2022